Recently, ergotamine concept stocks have emerged strongly, with several listed companies responding to related questions on interactive platforms. ① Chengzhi: The company's ergotamine is still in the small-scale testing phase. ② SIRIO: The company's U.S. subsidiary Best Formulations has the capability to produce NAD+ ergotamine cell energy capsules. The company is very optimistic about the development potential of the anti-aging market. In addition to ergotamine, the company has also laid out related products such as PQQ, quercetin, and Q10 that can be applied in anti-aging scenarios. In February of this year, the company announced the establishment of an anti-aging research institute, aiming to focus on "scientific research innovation + industrial transformation," with a focus on four major areas: cellular systems, probiotics and the gut, muscle joints, and women's ovaries. ③ WanBang Pharmaceutical: The company provides clinical efficacy testing services for an ergotamine eye wash project aimed at improving dry eye syndrome. ④ FUSHILAI: The company currently has no ergotamine-related business